Other OTC - Delayed Quote USD

Nanalysis Scientific Corp. (NSCIF)

0.3310 0.0000 (0.00%)
At close: April 25 at 11:21 AM EDT
Key Events
Loading Chart for NSCIF
DELL
  • Previous Close 0.3310
  • Open 0.3310
  • Bid --
  • Ask --
  • Day's Range 0.3310 - 0.3310
  • 52 Week Range 0.2510 - 0.4950
  • Volume 79,782
  • Avg. Volume 87,249
  • Market Cap (intraday) 37.25M
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date Apr 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.

www.nanalysis.com

249

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NSCIF

Performance Overview: NSCIF

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NSCIF
19.06%
S&P/TSX Composite index
4.82%

1-Year Return

NSCIF
28.82%
S&P/TSX Composite index
7.48%

3-Year Return

NSCIF
11.00%
S&P/TSX Composite index
15.01%

5-Year Return

NSCIF
--
S&P/TSX Composite index
58.06%

Compare To: NSCIF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NSCIF

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    36.25M

  • Enterprise Value

    48.59M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.71

  • Price/Book (mrq)

    2.01

  • Enterprise Value/Revenue

    1.88

  • Enterprise Value/EBITDA

    -3.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -65.57%

  • Return on Assets (ttm)

    -15.68%

  • Return on Equity (ttm)

    -47.87%

  • Revenue (ttm)

    25.87M

  • Net Income Avi to Common (ttm)

    -16.96M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.27M

  • Total Debt/Equity (mrq)

    71.36%

  • Levered Free Cash Flow (ttm)

    -9.55M

Company Insights: NSCIF

People Also Watch